As an industry first, Avida Biomed has fully automated its novel Point-n-Seq^® targeted sequencing sample prep as well as targeted methylation enrichment to a <1 day protocol, including only 10-15 minutes of hands-on time,  - all achieved on Opentrons' low cost open-platform liquid handler, the OT-2.

Avida’s targeted sequencing Point-n-Seq 500 (PnS 500) assay accurately detects oncogenic variants (SNV, CNV and fusion) in both FFPE and cfDNA samples. It outperforms a market-leading oncology assay with a shorter total turnaround time, better uniformity, and greater flexibility. 

Combined, Avida and Opentrons provide the only commercially available fully automated solution of targeted methylation NGS sample prep with unprecedented recovery and LOD. 

Sign up to receive 60-minute webinar to learn:

• The first walk-away, automated workflow for targeted methylation NGS library prep
• Opentrons OT-2's ability to greatly reduce sample prep total turnaround and hands-on time
• The superior performance of Avida's automated PnS 500 assay for accurate variant detection with FFPE and cfDNA reference

Who should watch:

• Genomic Scientists
• NGS Lab Technicians 
• NGS Lab Managers or Directors 
• Automation Specialists or Engineers

Subject to your consent given above, by clicking on "GET THE WEBINAR", Opentrons and Avida Biomed may share your personal information to communicate with you for marketing purposes, including information about this topic, promotional offers and news. This use of your personal information is an exception to our Privacy Policy.

Grace Zhao, Ph.D.

Co-Founder, Avida Biomed

Dr. Zhao co-invented a novel platform technology for highly efficient DNA enrichment for NGS sample prep, the Point-n-Seq system, enabling ultra-sensitive and low-cost cfDNA mutation, methylation, or dual analysis.